Cargando…
Treatment of stroke in aged male and female rats with Vepoloxamer and tPA reduces neurovascular damage
Stroke is a leading cause of death and disability worldwide, mainly affecting the elderly. Unfortunately, current treatments for acute ischemic stroke warrant improvement. To date, tissue plasminogen activator (tPA) is of limited use in stroke patients mainly due to its narrow therapeutic window and...
Autores principales: | Zhang, Li, Luo, Hao, Li, Chao, Teng, Hua, Powell, Brianna, Lu, Mei, Chopp, Michael, Zhang, Zheng Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587547/ https://www.ncbi.nlm.nih.gov/pubmed/37869138 http://dx.doi.org/10.3389/fneur.2023.1282736 |
Ejemplares similares
-
Targeting microthrombosis and neuroinflammation with vepoloxamer for therapeutic neuroprotection after traumatic brain injury
por: Xiong, Ye, et al.
Publicado: (2018) -
Post-Stroke Administration of L-4F Promotes Neurovascular and White Matter Remodeling in Type-2 Diabetic Stroke Mice
por: Zhou, Min, et al.
Publicado: (2022) -
J147 Reduces tPA-Induced Brain Hemorrhage in Acute Experimental Stroke in Rats
por: Jin, Rong, et al.
Publicado: (2022) -
Intravenous thrombolysis with 0.65 mg/kg r-tPA may be optimal for Chinese mild-to-moderate stroke
por: Cui, Yu, et al.
Publicado: (2022) -
Optimal Delay Time of CT Perfusion for Predicting Cerebral Parenchymal Hematoma After Intra-Arterial tPA Treatment
por: Wu, Bing, et al.
Publicado: (2018)